Shanjana Awasthi, Ph.D.

---

Summary

Research in my lab is focused on developing immunotherapeutics and vaccines by harnessing our body's natural host defense mechanisms. Our research efforts have been focused on developing TLR4-interacting surfactant protein-A-derived peptides and dendritic cell-based vaccine approaches. We are interested in investigating the mechanisms of action and efficacy of these approaches using structural, computational, physicochemical, and immunological tools and methods, and in vitro and in animal models of infection, inflammation and cancer.

Certifications & Licenses

---

Publications & Presentations

71. Awasthi S, Coalson J J, Yoder B A, Crouch E, King R J. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. American journal of respiratory and critical care medicine. 2001; 163 : 389-97

72. Vivekananda J, Awasthi V, Awasthi S, Smith D B, King R J. Hepatocyte growth factor is elevated in chronic lung injury and inhibits surfactant metabolism. American journal of physiology. Lung cellular and molecular physiology. 2000; 278 : L382-92

73. Awasthi S, Coalson J J, Crouch E, Yang F, King R J. Surfactant proteins A and D in premature baboons with chronic lung injury (Bronchopulmonary dysplasia). Evidence for an inhibition of secretion. American journal of respiratory and critical care medicine. 1999; 160 : 942-9

74. Awasthi S, Coalson J J, Crouch E, King R J. Differential regulation of secretion of SP-A and SP-D in neonatal baboons with chronic lung injury. FASEB Journal. 1998; 12

75. S S, Dhole T, Prasad K, Ayyagari A. Evaluation of 66kDa directed IgG response for detection of Helicobacter pylori infection. Indian Journal of Medical Microiology. 1996; 14 : 17-21

Grants

1. Surfactant protein-A regions as TLR4-immunomodulators. NIH. Start Date: 2017. End Date: 2023.

2. Molecular mechanism of action of TLR4-interacting SPA4 peptide in lung epithelial cell systems. Non-federal. Start Date: 2021. End Date: 2022.

3. Immunomodulation by a TLR4-interacting Surfactant protein-A peptide. Non-federal. Start Date: 2013. End Date: 2021.

4. Control of lung inflammation by a TLR4-interacting SP-A-derived peptide. NIH. Start Date: 2013. End Date: 2017.

5. Structure-function relation of a TLR4-interacting Surfactant protein-A-derived peptide. NIH. Start Date: 2013. End Date: 2014.

Awards and Honors

1. Office of Technology Development, OUHSC. Patent Award. Date: 2014.


2. Tech Connect Ventures in partnership with Blue Origin and Sierra Space. Finalist of Reef Starter Innovation Challenge. Date: 2022.

Education

1. Degree: Post-Baccalaureate Categorical certificate in Clinical Microbiology. University of Texas Health Sciences Center at San Antonio. Date: 2006.


2. Degree: Ph D. Sanjay Gandhi Post Graduate Institute of Medical Sciences. Date: 1995.


3. Degree: Master of Science. Indian Institute of Technology (IIT). Date: 1990.


4. Degree: Bachelor of Science. MKP College, University of Garhwal. Date: 1988.

Administrative Assignments

no results

External Connections and Partnerships

1. Type: Funding. Org: Oklahoma State University (2013-2017). City: Stillwater. State: Oklahoma. NIH-supported COBRE program in Respiratory and Infectious Diseases. Date: 2013.


2. Type: Funding. Org: University of Oklahoma (2013-2014). City: Norman. State: Oklahoma. NIH-supported COBRE program in Structural Biology. Date: 2013.